{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:36:09Z","timestamp":1766579769907},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic obstructive pulmonary disease (COPD) is a leading cause of death world-wide. Recently, we showed that COPD is associated with gene polymorphisms in <jats:italic>SUMF1<\/jats:italic>, a master regulator of sulfatases. Sulfatases are involved in extracellular matrix remodeling and activated by SUMF1, but their role in the lung is poorly described. We aimed to examine how sulfatases are affected in the airways of patients with COPD compared to ever smokers and never smokers. We observed that mRNA expression of the sulfatases <jats:italic>GALNS<\/jats:italic>, <jats:italic>GNS<\/jats:italic> and <jats:italic>IDS<\/jats:italic> was increased, while protein expression of many sulfatases was decreased in COPD fibroblasts. Several sulfatases, including GALNS, IDS, and SGSH, showed increased activity in COPD fibroblasts. Examination of different sulfatases by immunofluorescence showed that IDS, ARSB, GNS and SGSH in fibroblasts were localized to sites other than their reported destination. Using a master panel from different organs, RNA expression of all sulfatases could be observed in lung tissue. Additionally, immunohistochemistry on lung biopsies indicated differing expression of sulfatases in COPD patients. In conclusion, mRNA, protein expression, sulfatase activity levels, and localization of sulfatases are altered in lung fibroblasts and lung tissue from COPD patients and may be mechanistically important in COPD pathogenesis. This could contribute to the understanding of the disease mechanism in COPD and in the long run, to lead to more individualized therapies.<\/jats:p>","DOI":"10.1038\/s41598-018-37958-w","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T11:05:13Z","timestamp":1550055913000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Expression, activity and localization of lysosomal sulfatases in Chronic Obstructive Pulmonary Disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Julie","family":"Weidner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajakta","family":"Jogdand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linnea","family":"Jarenb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"\u00c5berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalja","family":"Helihel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaro","family":"Ankerst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunilla","family":"Westergren-Thorsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif","family":"Bjermer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas S.","family":"Erjef\u00e4lt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Tufvesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"37958_CR1","unstructured":"WHO. World Health Organization: The top 10 causes of death at, http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/ (2017)."},{"key":"37958_CR2","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1172\/JCI60324","volume":"122","author":"RM Tuder","year":"2012","unstructured":"Tuder, R. M. & Petrache, I. Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest 122, 2749\u20132755, https:\/\/doi.org\/10.1172\/JCI60324 (2012).","journal-title":"J Clin Invest"},{"key":"37958_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ccm.2013.10.008","volume":"35","author":"SJ Marciniak","year":"2014","unstructured":"Marciniak, S. J. & Lomas, D. A. Genetic susceptibility. Clin Chest Med 35, 29\u201338, https:\/\/doi.org\/10.1016\/j.ccm.2013.10.008 (2014).","journal-title":"Clin Chest Med"},{"key":"37958_CR4","unstructured":"GOLD. Global Iniative for Chronic Lung Disease: Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2018)."},{"key":"37958_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00018-009-0203-3","volume":"67","author":"M Buono","year":"2010","unstructured":"Buono, M. & Cosma, M. P. Sulfatase activities towards the regulation of cell metabolism and signaling in mammals. Cell Mol Life Sci 67, 769\u2013780, https:\/\/doi.org\/10.1007\/s00018-009-0203-3 (2010).","journal-title":"Cell Mol Life Sci"},{"key":"37958_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.genom.6.080604.162334","volume":"6","author":"G Diez-Roux","year":"2005","unstructured":"Diez-Roux, G. & Ballabio, A. Sulfatases and human disease. Annu Rev Genomics Hum Genet 6, 355\u2013379, https:\/\/doi.org\/10.1146\/annurev.genom.6.080604.162334 (2005).","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"37958_CR7","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1002\/anie.200300632","volume":"43","author":"SR Hanson","year":"2004","unstructured":"Hanson, S. R., Best, M. D. & Wong, C. H. Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl 43, 5736\u20135763, https:\/\/doi.org\/10.1002\/anie.200300632 (2004).","journal-title":"Angew Chem Int Ed Engl"},{"key":"37958_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0092-8674(03)00347-7","volume":"113","author":"T Dierks","year":"2003","unstructured":"Dierks, T. et al. Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme. Cell 113, 435\u2013444 (2003).","journal-title":"Cell"},{"key":"37958_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0092-8674(03)00348-9","volume":"113","author":"MP Cosma","year":"2003","unstructured":"Cosma, M. P. et al. The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases. Cell 113, 445\u2013456 (2003).","journal-title":"Cell"},{"key":"37958_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10545-015-9903-z","volume":"39","author":"F Sasarman","year":"2016","unstructured":"Sasarman, F. et al. Biosynthesis of glycosaminoglycans: associated disorders and biochemical tests. J Inherit Metab Dis 39, 173\u2013188, https:\/\/doi.org\/10.1007\/s10545-015-9903-z (2016).","journal-title":"J Inherit Metab Dis"},{"key":"37958_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/path.4808","volume":"240","author":"JK Burgess","year":"2016","unstructured":"Burgess, J. K., Mauad, T., Tjin, G., Karlsson, J. C. & Westergren-Thorsson, G. The extracellular matrix - the under-recognized element in lung disease? J Pathol 240, 397\u2013409, https:\/\/doi.org\/10.1002\/path.4808 (2016).","journal-title":"J Pathol"},{"key":"37958_CR12","doi-asserted-by":"publisher","unstructured":"Burgstaller, G. et al. The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease. Eur Respir J 50, https:\/\/doi.org\/10.1183\/13993003.01805-2016 (2017).","DOI":"10.1183\/13993003.01805-2016"},{"key":"37958_CR13","doi-asserted-by":"publisher","first-page":"11388","DOI":"10.1074\/jbc.M709917200","volume":"283","author":"MA Frese","year":"2008","unstructured":"Frese, M. A., Schulz, S. & Dierks, T. Arylsulfatase G, a novel lysosomal sulfatase. J Biol Chem 283, 11388\u201311395, https:\/\/doi.org\/10.1074\/jbc.M709917200 (2008).","journal-title":"J Biol Chem"},{"key":"37958_CR14","doi-asserted-by":"publisher","first-page":"30019","DOI":"10.1074\/jbc.M113.499541","volume":"288","author":"EM Wiegmann","year":"2013","unstructured":"Wiegmann, E. M. et al. Arylsulfatase K, a novel lysosomal sulfatase. J Biol Chem 288, 30019\u201330028, https:\/\/doi.org\/10.1074\/jbc.M113.499541 (2013).","journal-title":"J Biol Chem"},{"key":"37958_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.matbio.2012.02.001","volume":"31","author":"E Arteaga-Solis","year":"2012","unstructured":"Arteaga-Solis, E., Settembre, C., Ballabio, A. & Karsenty, G. Sulfatases are determinants of alveolar formation. Matrix Biol 31, 253\u2013260, https:\/\/doi.org\/10.1016\/j.matbio.2012.02.001 (2012).","journal-title":"Matrix Biol"},{"key":"37958_CR16","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1073\/pnas.0700382104","volume":"104","author":"C Settembre","year":"2007","unstructured":"Settembre, C. et al. Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency. Proc Natl Acad Sci USA 104, 4506\u20134511, https:\/\/doi.org\/10.1073\/pnas.0700382104 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"37958_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cell.2005.03.001","volume":"121","author":"T Dierks","year":"2005","unstructured":"Dierks, T. et al. Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation of the human formylglycine-generating enzyme. Cell 121, 541\u2013552, https:\/\/doi.org\/10.1016\/j.cell.2005.03.001 (2005).","journal-title":"Cell"},{"key":"37958_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1042\/BJ20061783","volume":"403","author":"A Fraldi","year":"2007","unstructured":"Fraldi, A. et al. SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies. Biochem J 403, 305\u2013312, https:\/\/doi.org\/10.1042\/BJ20061783 (2007).","journal-title":"Biochem J"},{"key":"37958_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ejhg.2010.219","volume":"19","author":"L Schlotawa","year":"2011","unstructured":"Schlotawa, L. et al. SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency. Eur J Hum Genet 19, 253\u2013261, https:\/\/doi.org\/10.1038\/ejhg.2010.219 (2011).","journal-title":"Eur J Hum Genet"},{"key":"37958_CR20","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/ajmg.a.35498","volume":"158A","author":"SH Hong","year":"2012","unstructured":"Hong, S. H. et al. Auditory characteristics and therapeutic effects of enzyme replacement in mouse model of the mucopolysaccharidosis (MPS) II. Am J Med Genet A 158A, 2131\u20132138, https:\/\/doi.org\/10.1002\/ajmg.a.35498 (2012).","journal-title":"Am J Med Genet A"},{"key":"37958_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10059-010-0083-2","volume":"30","author":"SC Jung","year":"2010","unstructured":"Jung, S. C. et al. Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2\/8 vector-mediated gene therapy. Mol Cells 30, 13\u201318, https:\/\/doi.org\/10.1007\/s10059-010-0083-2 (2010).","journal-title":"Mol Cells"},{"key":"37958_CR22","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1101\/gad.1735508","volume":"22","author":"R Khatri","year":"2008","unstructured":"Khatri, R. & Schipani, E. About the importance of being desulfated. Genes Dev 22, 2750\u20132754, https:\/\/doi.org\/10.1101\/gad.1735508 (2008).","journal-title":"Genes Dev"},{"key":"37958_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1476-5381.2009.00279.x","volume":"157","author":"E Papakonstantinou","year":"2009","unstructured":"Papakonstantinou, E. & Karakiulakis, G. The \u2018sweet\u2019 and \u2018bitter\u2019 involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance. Br J Pharmacol 157, 1111\u20131127, https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00279.x (2009).","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"37958_CR24","first-page":"107","volume":"12","author":"A Tylki-Szymanska","year":"2014","unstructured":"Tylki-Szymanska, A. Mucopolysaccharidosis type II, Hunter\u2019s syndrome. Pediatr Endocrinol Rev 12(Suppl 1), 107\u2013113 (2014).","journal-title":"Pediatr Endocrinol Rev"},{"issue":"Suppl 1","key":"37958_CR25","first-page":"133","volume":"12","author":"JA Gilkes","year":"2014","unstructured":"Gilkes, J. A. & Heldermon, C. D. Mucopolysaccharidosis III (Sanfilippo Syndrome)- disease presentation and experimental therapies. Pediatr Endocrinol Rev 12(Suppl 1), 133\u2013140 (2014).","journal-title":"Pediatr Endocrinol Rev"},{"key":"37958_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0562-5","volume":"18","author":"J Weidner","year":"2017","unstructured":"Weidner, J. et al. Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease. Respiratory research 18, 77, https:\/\/doi.org\/10.1186\/s12931-017-0562-5 (2017).","journal-title":"Respiratory research"},{"issue":"Suppl 1","key":"37958_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1752-699X.2010.00190.x","volume":"4","author":"G Westergren-Thorsson","year":"2010","unstructured":"Westergren-Thorsson, G. et al. Pathological airway remodelling in inflammation. Clin Respir J. 4(Suppl 1), 1\u20138, https:\/\/doi.org\/10.1111\/j.1752-699X.2010.00190.x (2010).","journal-title":"Clin Respir J."},{"key":"37958_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3565","volume":"14","author":"C Settembre","year":"2013","unstructured":"Settembre, C., Fraldi, A., Medina, D. L. & Ballabio, A. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol 14, 283\u2013296, https:\/\/doi.org\/10.1038\/nrm3565 (2013).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"37958_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biocel.2016.12.005","volume":"83","author":"G Westergren-Thorsson","year":"2017","unstructured":"Westergren-Thorsson, G. et al. Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 83, 27\u201338, https:\/\/doi.org\/10.1016\/j.biocel.2016.12.005 (2017).","journal-title":"Int J Biochem Cell Biol"},{"key":"37958_CR30","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/BF00711508","volume":"16","author":"W He","year":"1993","unstructured":"He, W., Voznyi, Y. V., Boer, A. M., Kleijer, W. J. & van Diggelen, O. P. A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease type D (MPS IIID). J Inherit Metab Dis 16, 935\u2013941 (1993).","journal-title":"J Inherit Metab Dis"},{"key":"37958_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/BF01799255","volume":"19","author":"EA Karpova","year":"1996","unstructured":"Karpova, E. A. et al. A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease type A (MPS IIIA). J Inherit Metab Dis 19, 278\u2013285 (1996).","journal-title":"J Inherit Metab Dis"},{"key":"37958_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0009-8981(79)90396-6","volume":"92","author":"L Svennerholm","year":"1979","unstructured":"Svennerholm, L., Hakansson, G., Mansson, J. E. & Vanier, M. T. The assay of sphingolipid hydrolases in white blood cells with labelled natural substrates. Clin Chim Acta 92, 53\u201364 (1979).","journal-title":"Clin Chim Acta"},{"key":"37958_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0009-8981(90)90339-T","volume":"187","author":"OP van Diggelen","year":"1990","unstructured":"van Diggelen, O. P. et al. A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A). Clin Chim Acta 187, 131\u2013139 (1990).","journal-title":"Clin Chim Acta"},{"key":"37958_CR34","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1023\/A:1012763026526","volume":"24","author":"YV Voznyi","year":"2001","unstructured":"Voznyi, Y. V., Keulemans, J. L. & van Diggelen, O. P. A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease). J Inherit Metab Dis 24, 675\u2013680 (2001).","journal-title":"J Inherit Metab Dis"},{"key":"37958_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1203\/00006450-197505000-00003","volume":"9","author":"NG Beratis","year":"1975","unstructured":"Beratis, N. G., Turner, B. M., Weiss, R. & Hirschhorn, K. Arylsulfatase B deficiency in Maroteaux-Lamy syndrome: Cellular studies and carrier identification. Pediatr Res 9, 475\u2013480 (1975).","journal-title":"Pediatr Res"},{"key":"37958_CR36","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/BF00710299","volume":"16","author":"YV Voznyi","year":"1993","unstructured":"Voznyi, Y. V. et al. A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease C (MPS III C). J Inherit Metab Dis 16, 465\u2013472 (1993).","journal-title":"J Inherit Metab Dis"},{"key":"37958_CR37","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1183\/09031936.05.00034905","volume":"26","author":"N Macintyre","year":"2005","unstructured":"Macintyre, N. et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26, 720\u2013735, https:\/\/doi.org\/10.1183\/09031936.05.00034905 (2005).","journal-title":"Eur Respir J"},{"key":"37958_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller, M. R. et al. Standardisation of spirometry. Eur Respir J 26, 319\u2013338, https:\/\/doi.org\/10.1183\/09031936.05.00034805 (2005).","journal-title":"Eur Respir J"},{"key":"37958_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1183\/09031936.05.00035005","volume":"26","author":"J Wanger","year":"2005","unstructured":"Wanger, J. et al. Standardisation of the measurement of lung volumes. Eur Respir J 26, 511\u2013522, https:\/\/doi.org\/10.1183\/09031936.05.00035005 (2005).","journal-title":"Eur Respir J"},{"key":"37958_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.plefa.2011.04.025","volume":"85","author":"E Tufvesson","year":"2011","unstructured":"Tufvesson, E., Nihlberg, K., Westergren-Thorsson, G. & Bjermer, L. Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls. Prostaglandins Leukot Essent Fatty Acids 85, 67\u201373, https:\/\/doi.org\/10.1016\/j.plefa.2011.04.025 (2011).","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37958-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37958-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37958-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:00:14Z","timestamp":1671256814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37958-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37958"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37958-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"25 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1991"}}